Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4(+) and CD8(+) T effector memory cells and increase of T regulatory cells Journal Article


Authors: Karantanos, T.; Kim, H. T.; Tijaro-Ovalle, N. M.; Li, L.; Cutler, C.; Antin, J. H.; Ballen, K.; Marty, F. M.; Tan, C. S.; Ritz, J.; Politikos, I.; Boussiotis, V.
Article Title: Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4(+) and CD8(+) T effector memory cells and increase of T regulatory cells
Abstract: BK virus (BKV), a human polyomavirus that remains latent in renal epithelial cells, can be reactivated after hematopoietic stem cell transplantation (HSCT) leading to hemorrhagic cystitis. The incidence of BK viremia is higher after Umbilical cord blood transplantation (UCBT) than HSCT from adult donors. Data regarding the role of immune recovery after UCBT in BKV reactivation is lacking. We examined the correlation between the development of BK viremia and immune reconstitution in 27 adult recipients of UCBT. The incidence of BK viremia was 52% and developed most frequently within the first 8 weeks after the transplantation, but persisted in seven patients at 6 months, and three patients at 1-year post UCBT. Detection of BK viremia 1 year after transplant was negatively associated with the number of CD8+ cells (p = 0.03) and CD8+CD45RO+ cells (p = 0.05) at 6 months, and the number of CD4+ (p = 0.03) and CD4+CD45RO+ cells (p = 0.03) at 12 months after UCBT. Conversely, BK viremia at 6 and 12 months was positively correlated with the number of T regulatory (Treg) cells at 1 month (p = 0.005 and p = 0.016, respectively). Because UCB Treg have highly potent immunosuppressive function, our findings indicate that sustained BK viremia in UCBT recipients might be associated with the increase of Treg cells early after transplantation, which mediate impaired and delayed reconstitution of CD4+ and CD8+ T effector cells. © 2019 Elsevier Inc.
Journal Title: Clinical Immunology
Volume: 207
ISSN: 1521-6616
Publisher: Elsevier Inc.  
Date Published: 2019-10-01
Start Page: 18
End Page: 23
Language: English
DOI: 10.1016/j.clim.2019.06.010
PROVIDER: scopus
PUBMED: 31255803
DOI/URL:
Notes: Source: Scopus
Altmetric Score
MSK Authors